Skip to main content
Clinical Trials/IRCT2017022231875N3
IRCT2017022231875N3CompletedPhase 3

Effect of the Training Program on Balance, Motor Function, Proprioceptive Sense and Walking speed of Patients with Diabetic Neuropathy

Vice chancellor for research, Golestan University of Medical Sciences0 sites44 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
44

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30 years to 75 years (—)
Sex
All

Inclusion Criteria

  • Diabetes for at least 5 years; Diagnosis of Diabetic Peripheral Neuropathy with Score Greater than 2 by Michigan Neuropathy Screening Instrument (MNSI); Visual Acuity of 20/ 40 by Snellen Chart; Normal Range of Motion of the Hip, Knee and Ankle Joint; Ability to Stand and Walk; Independently and without Assistive Devices; Filling the Informed Consent Form.
  • Exclusion criteria: Foot Ulceration and Lower Limb Deformity; History of Surgery or Chronic Pain in the Lower Extremity or Low Back; History of Hypotension, Myocardial Infarction and Stroke; Other Peripheral Neurologic and Musculoskeletal Disorders; Using Drugs Effective on Balance during the Examination to Test.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Golestan University of Medical Sciences

Similar Trials